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Abstract
Background: Linkage studies often yield intervals containing several hundred positional candidate genes. Different manual
or automatic approaches exist for the determination of the gene most likely to cause the disease. While the manual search is
very flexible and takes advantage of the researchers’ background knowledge and intuition, it may be very cumbersome to
collect and study the relevant data. Automatic solutions on the other hand usually focus on certain models, remain ‘‘black
boxes’’ and do not offer the same degree of flexibility.
Methodology: We have developed a web-based application that combines the advantages of both approaches.
Information from various data sources such as gene-phenotype associations, gene expression patterns and protein-protein
interactions was integrated into a central database. Researchers can select which information for the genes within a
candidate interval or for single genes shall be displayed. Genes can also interactively be filtered, sorted and prioritised
according to criteria derived from the background knowledge and preconception of the disease under scrutiny.
Conclusions: GeneDistiller provides knowledge-driven, fully interactive and intuitive access to multiple data sources. It
displays maximum relevant information, while saving the user from drowning in the flood of data. A typical query takes less
than two seconds, thus allowing an interactive and explorative approach to the hunt for the candidate gene.
Access: GeneDistiller can be freely accessed at http://www.genedistiller.org
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Introduction
In recent years, genetic defects have been discovered for
many monogenic diseases through linkage analysis, candidate
gene approaches or a combination thereof. Crucial for this
success were the access to large affected families in sufficient
numbers or the availability of animal models that closely
mimicked the human disease phenotype. However, of more
than 25,000 human protein coding genes listed in the Entrez
database, less than 2,000 have been associated with human
disease phenotypes [1]. Geneticists are increasingly confronted
with smaller families affected with rare conditions that carry
‘‘private’’ mutations. Nevertheless, elucidation of the gene
defects in such single families has opened whole new research
areas (e.g. the KE family for FOXP2 [2] in language
development and the ‘‘Muscle baby’’ for Myostatin in muscle
research [2,3]). Linkage analyses of these small pedigrees have
thus to be performed with relatively few meioses leading to more
than one or to larger candidate intervals over 10 cM, whose
LOD scores may remain below the threshold for significance of
3. Such large intervals may contain several hundred genes that
have to be prioritised for mutation screening before labour and
cost intensive gene sequencing is initiated.
The conventional manual approach usually does not follow any
strict algorithm but is guided by the background knowledge and
expectations of the researcher (Figure 1). In a conventional setting,
this involves a search for all known genes in the linkage interval
and a subsequent query of different databases to gather available
data and extract the relevant information for prioritisation.
Assessment of the validity of a positional candidate requires a
thorough knowledge of many data relevant to the gene or protein
of interest. Most of this information can be found on the Internet,
but it is tedious to collect the fragments from different data
sources. While some tools offer maps showing all genes within a
region (NCBI MapViewer [4], UCSC Genome Browser [5])
without any gene-specific information, others (GeneCards [6])
feature detailed genetic data but only for one single gene at a time.
Besides, all these tools suffer from the lack of more elaborate query
options refining the output to a well-defined group of genes.
In the past, several interactive, automatic or semiautomatic
approaches to search for disease genes have been proposed [7] or
implemented such as Endeavour [8], GeneWanderer [9],
GeneSeeker [10], GeneSniffer (http://www.genesniffer.org/),
PosMed (http://omicspace.riken.jp/PosMed/) and SUSPECTS
[11]. Some applications classify genes based on sequence features
[12], or use protein-protein interaction networks [9,13] while
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For the researchers, however, the algorithms of these programs
remain largely inaccessible. In a meta-test of three software tools
for automatic gene prioritisation of positional candidate genes the
authors recommend to exert caution in relying solely on single
positional candidate prioritisation tools [14]. In any case, a
researcher would usually want to read relevant gene specific
information for the proposed candidate genes her- or himself
before embarking upon a large sequencing project.
GeneDistiller is aimed at various strategies. It can either be used
as a tool to query, select and project genes from within a linkage
interval together with gene specific data or to display rich
information on human candidate genes obtained with other
prioritisation tools or of the researcher’s interest. Besides, it offers a
customisable user-driven prioritisation integrating the available
data as specified by the researcher. The application is web-based
and features an intuitive interface which enables the researcher to
formulate simple queries without the need to read a software
manual before, yet allowing more complex queries. The software
returns all results on one HTML page which can easily be printed
or saved. The kind of information included is determined by the
researcher. Since the results of a search are presented on the fly,
the software offers a high degree of interactivity, allowing the
researcher to quickly change some parameters to follow new ideas
which may arise when reading the results. She can thus explore the
data with the help of the computer and combine newly gained
insights with her background knowledge (Figure 2).
Results
Strategies
GeneDistiller offers different approaches to determine the most
likely candidate genes:
Projection. GeneDistiller can list all genes within a linkage
interval together with gene specific information. Among the
different kinds of gene specific data, the researcher can select those
relevant to her and print and read this information for all
positional candidates to choose the most promising gene. This
approach can be very helpful if she has only a vague idea of the
disease causing gene.
Selection. The researcher can apply filters to the genes in the
linkage interval, thus narrowing down their number to a small
group of more promising candidates (Figure 3). This approach
should be applied when the researcher is able to define conditions
Figure 2. The GeneDistillery. The user-friendly interface allows the researchers to incorporate their background knowledge about diseases and
genes into the interactive ‘‘gene distilling’’ process. They can extract all the information relevant to their specific question at our one-stop shop. This
saves them from drowning in the flood of data available on the WWW and helps them to determine the most promising candidates.
doi:10.1371/journal.pone.0003874.g002
Figure 1. Strategies / Possibilities. This scheme illustrates different approaches to choose reasonable candidate genes from a linkage interval.
The researcher can either follow a hypothesis driven approach based on a functional model or simply choose genes based on single properties
reflecting the likelihood of being disease causing, e.g. the co-expression with other disease genes that cause similar phenotypes. The general
concepts are depicted as pink boxes, gene properties that can be queried by GeneDistiller as yellow boxes, and properties or models GeneDistiller
presently does not offer as blue boxes. With GeneDistiller, the user is absolutely free to combine gene properties according to her or his own
hypotheses.
doi:10.1371/journal.pone.0003874.g001
GeneDistiller
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certain tissue or co-expression with another gene. Alternatively,
‘‘visual’’ filters can be used to highlight gene properties so that no
gene will be excluded.
Sorting. Genes can be sorted according to certain parameters,
e.g. their position, tissue specific expression or likelihood to encode
mitochondrial proteins.
Prioritisation. GeneDistiller offers a user-driven prioritisation
function which ranks genes according to the researcher’s
specifications. Prioritisation approaches should be used when the
researcher cannot excludeanygeneinadvancebutwants to focuson
the genes in falling order of ‘‘apparent’’ relevance.
The user is free to combine these methods to follow a strategy
which best suits the problem, e.g. she can exclude genes using
filters, choose the parameters to be used in the prioritisation
process, select those to be displayed in the output and highlight
interesting properties.
Application of the different strategies
While some researchers prefer to read the available information
for all genes within a candidate interval, others may rather narrow
down the number of genes beforehand and focus on those fulfilling
certain conditions that are regarded as mandatory. We describe
the application of the two latter approaches which are more
complex and most commonly used, selection (filtering) and
prioritisation, here together with valid ‘‘real life’’ examples. More
examples are given on our website and help page.
Selection (Figure 3). Imagine, a candidate locus for epilepsy
could be mapped to a 60 Mbp region on chromosome 2. Entering
the markers limiting the interval will yield 362 genes. Since
epilepsy is a common disease and a well-studied subject, the
researcher might wish to focus on those genes that are known to
show a suitable phenotype in an animal model. She thus filters the
genes for their described mouse phenotypes. By selecting nervous
system phenotype and behaviour/neurological phenotype from the MGD
phenotypes drop-down menu and limiting the query to the respective
genes, the number of genes can be significantly reduced to 35
genes which are linked to at least one of these phenotypes. A
further condensation can be reached when the descriptions for
human phenotypes are considered: The researcher enters the
broad term brain into the field highlight these keywords and restricts the
search to genes in whose descriptions one of these keywords
appear. The more specific word epilepsy is not used because she
does not want to restrain her search to genes already known to
cause epilepsy in humans. The list now contains 25 candidate
genes. Since a gene responsible for epilepsy is likely to be expressed
in brain, she now opens the expression tab and selects .1 (x median)
for the expression in whole brain. Restriction to the genes with an
expression above the median can be reached when show only genes
fulfilling the conditions is selected and will yield 17 genes. From
functional studies with her patients she knows that the prefrontal
cortex might be involved and decides to focus on genes with a
notable expression there. Setting a filter for prefrontal cortex expression
.3 (x median) and connecting both expression filters with AND
shortens the list to only 7 genes. As many epilepsy genes involve
ion channels she could further reduce the number of genes by
adding the Gene Ontology ID for ion transport (GO:0006811) into
the highlight these GO IDs fields and restrict the search to those
carrying this GO ID or a subclass. Now, only 2 genes, SCN1A and
SCN3A remain in the list both of which are excellent candidates for
an epilepsy phenotype.
Prioritisation. For prioritisation the researcher can easily
incorporate his or her background knowledge and follow various
search avenues alone or in combination. GeneDistiller features
Figure 3. Filtering. This figure shows how filters can be applied in GeneDistiller to reduce the number of genes to be studied. After defining the
linkage interval, more and more selection criteria can be added by the researcher, narrowing down the genes to ever more likely candidates. The
example depicts the hunt for candidate genes for epilepsy in a 60 Mbp region on chromosome 2. The size of a rectangle is proportional to the
number of genes and the grey shades reflect the ‘‘distillation’’ process in which the best candidates are enriched.
doi:10.1371/journal.pone.0003874.g003
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prioritisation. In the output, GeneDistiller shows scores for each
of the parameters chosen for the prioritisation so that the
researcher can easily modify the weights given to the different
parameters if she wants to shift the focus to certain aspects.
The disease under investigation may have a similar phenotype
as a disease with a known gene defect or a transgenic mouse
model. In this case the search comprises genes within the
candidate region that are either known to be causing a similar
phenotype in humans or mice or relate to disease-causing genes by
experimentally proven protein-protein interactions, function in the
same biochemical or signal transduction pathway, sequence
similarities, similar protein domains or entries in the Gene
Ontology [15] or share similar mRNA expression patterns. The
latter approach stands in analogy to the credo of the neurophys-
iologist ‘‘Neurons that fire together, wire together’’, changed into ‘‘Disease-
linked genes more or less, co-express’’. The set of known disease genes
can either be defined by their gene symbol or gene ID or retrieved
from the database by specifying suitable OMIM IDs or terms.
Genes may also be prioritised according to their suspected
functional properties. The positional candidate may belong to a
certain functional group of genes (e.g. various sodium channel
proteins in Generalised Epilepsy with Febrile Seizures (GEFS+)
[16]), biochemical pathways (e.g. O-glycolysation defects in
congenital myopathies; FCMD, POMGNT1, POMT1, POMT2,
LARGE [17]) or sub-cellular organelles (e.g. impaired mitochon-
drial protein synthesis in mutations of mitochondrial elongation
factors EFG1 and TSFZ [18,19]).
Let us imagine the same situation as depicted in the example for
the selection approach with the same linkage interval. Instead of
filtering the data for genes fulfilling all criteria, the genes within the
linkage interval can also be prioritised according to their similarity
to genes already known to cause epilepsy. Here, the predefined
model prioritise with focus on possible pathways is chosen. We apply all
our background knowledge to the query, i.e. we want to focus on
genes with the assigned term brain, with known nervous system
phenotype or behaviour/neurological phenotype in mice, expression in the
relevant tissues and phenotypic, functional and expression
similarities with genes known to be involved in epilepsy (Figure 4).
As with the filtering approach, the best candidate, SCN1A, appears
on top of the list. Here, however, no genes are discarded so that
the researcher can scroll from the most to the least promising
candidate, read the gene specific data and also their accordance to
the prioritisation model as a whole and for every single parameter
(Figure 5).
Database schema and contents
The GeneDistiller database stores data from various sources
that are most frequently considered by researchers when manually
searching for candidate genes. All gene-specific data is stored in
satellite tables connected to a central database table GENES in
which the genes are defined. These connections are either
modelled as 1:1, 1:n or m:n relations, depending on the nature
of the data. The database schema therefore resembles the query-
optimised star schema found in many data warehouses (the
database schema can be found on GeneDistiller’s website).
Whenever database entities are defined by a stable numeric ID
in their original environment, GeneDistiller uses this ID to
facilitate later updates and hyperlinks to the original source. If such
an ID is not available and m:n relations must be modelled, an
internal serial numeric ID is used instead. This is also the case
when data from different sources are mixed in one table, e.g. for
SNP markers which are not all necessarily included in dbSNP. In
the schema, SNP and STR markers are not directly connected to
the genes. If marker and gene information is mixed in a query,
their physical position will be used.
The database schema makes extensive use of constraints to
guarantee referential integrity and to exclude worthless informa-
tion (e.g. genetic markers without a position). Dubious data (e.g.
markers with more than one position, except for gonosomal
markers) is either excluded or this state is indicated.
GeneDistiller includes the following data: Genes, gene positions,
gene RIFs, gene ontology, cellular localisation of gene products,
transcripts, exons, OMIM reports, mouse phenotypes, protein-
protein interactions, gene expression data, protein domains, SNP
markers, STR markers. A list of the external data presently
integrated in GeneDistiller is given in Table 1. More data will be
added in the future according to our and the community’s needs.
Whenever such data is displayed, a hyperlink to the original data
source is generated so that users have the chance to easily drill-
down the information. Besides, links to Genbank files via BioMart
[20] and to Exon-Primer (http://ihg2.helmholtz-muenchen.de/
ihg/ExonPrimer.html) are presented so that the researchers can
directly choose their sequencing primers without the need to
manually query a sequence database.
The data stored in the database is updated in regular intervals of
3 months. Further updates are performed whenever new data
sources are integrated. Here again, the strict quality control
measures described above are applied. Whenever data is queried,
a time-stamp is printed indicating the last update or version of the
data.
Interface
GeneDistiller is web-based; all interfaces are ordinary HTML
pages without any Java applications to be installed. In the query
interface (Figure 4), parameters are grouped into distinct blocks.
Some more advanced parameters such as tissue-specific expression
are not shown by default but all blocks can be switched on and off
at the researcher’s will.
To use GeneDistiller, in a first step, the possible candidate genes
have to be chosen. They can either be positional candidates from a
linkage interval or functional candidates. In the former case, the
interval can be defined by entering its position or limiting markers,
in the latter case, gene symbols or Entrez gene IDs can be
specified. The researcher can now select which information shall
be included in the output (or stick to the default settings suitable
for a first glance). Using these settings, the selected data would be
shown for all genes within the candidate interval.
To reduce the number of genes, filters can be applied by
specifying conditions. These can be defined either by selecting one
or more values from select boxes (when only a limited number of
values is stored in the respective database table, e.g. mouse
phenotypes) or by typing values. Depending on the parameter, the
corresponding property table is either searched for tuples with
exactly this value (e.g. GO IDs) or a full-text search is performed
(e.g. OMIM reports). When numeric values are stored in the
database, comparison operators (,,= ,.) can be applied (e.g. for
gene expression data). When the researcher does not want to
exclude genes but to emphasise those fulfilling the conditions, the
highlighting function can be used. In this case, keywords occurring
in the text or matching values will be printed in bold and, in full-
text, colour.
GeneDistiller supports the researcher with the option to sort or
prioritise the genes so that the more likely candidates appear on
top of the list. For sorting, a single parameter such as expression
similarity or likelihood of incorporation into mitochondria can be
chosen. Prioritisation offers even broader possibilities as different
parameters can be combined into the ranking. The researcher can
GeneDistiller
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itisation strategies (which focus on distinct approaches, e.g.
similarity or tissue-specificity) and is absolutely free to choose
further parameters to be included or lay more or less weight on
any of them. When prioritisation is applied, a detailed prioritisa-
tion score is printed for each gene so that it becomes clear which
parameter causes a gene to be highly ranked. Since a typical query
takes less than 2 seconds, the researcher can easily modify his or
her prioritisation settings on the basis of the results. The whole
prioritisation process is therefore completely transparent and user-
driven and allows a fast, intuitive, interactive and explorative
access to the results.
Output
GeneDistiller prints the results of a query in HTML format.
The resulting page (Figure 5) does not make use of colour unless
to highlight keywords chosen by the user. The genes are
presented together with all the desired data in an order specified
by the researcher and visually separated to increase readability.
The page also includes hyperlinks to the original data to simplify
access to more detailed data which might exist on the website of
the data source. Below the actual data, a timestamp or version of
the data is displayed. The page can be printed or saved for later
use. The output also features two hyperlinks, one to the results
page and one to the query interface with all current settings.
Bookmarking this hyperlink allows a researcher to return to the
query interface and change the query at any time without having
to fill out the form once again. It can also be shared with other
researchers so that they can refine the search on the basis of their
own background knowledge or focus and eventually return their
concept as another bookmarked query instead of a static list of
genes.
GeneDistiller can also be called and used from other
applications. Since all settings, e.g. regions, gene lists, information
to be displayed filtering criteria etc., can be specified in the call,
GeneDistiller can easily be integrated into other applications. This
can be especially worthwhile for prioritisation tools which could
extend their list of suggested candidate genes with gene specific
data from GeneDistiller, hence facilitate the decision to exclude
certain genes from sequencing.
Discussion
GeneDistiller is aimed at the geneticists themselves. We have
therefore developed an interface that is relatively easy to use.
While this makes the use of GeneDistiller quite intuitive, queries
with a high degree of complexity are not feasible. For example,
filters for different kinds of data are always joined by AND. While
an interface allowing to enter the Boolean logic might be useful to
some bioinformaticians, we believe that it would tend to confuse
the majority of geneticists.
Our software differs from the existing prioritisation tools
because we deeply integrate the geneticist into the gene hunting
process. In our opinion, the researcher’s background knowledge
and the human mind’s capabilities to spontaneously associate
information bear a potential that is neglected by automatic
solutions. In these, the researcher can give some information about
the nature of the disease before the data mining begins and
exclude (negatively select) suggested candidates afterwards but he
is not able to quickly apply his background knowledge in between,
i.e. on the basis of the results. This is further complicated because
most prioritisation tools lack the capability to display gene specific
data comprehensively. Reading the rich information printed by
GeneDistiller could also lead the researcher spontaneously to
completely new ideas, he might thus discover something he did not
expect.
However, GeneDistiller is not meant as a replacement for the
existing prioritisation tools. It does for example not at all offer the
same degree of sequence comparisons or evaluation of interaction
networks, calculations in which computers easily outperform
humans. We regard our software and automatic solutions as
supplemental approaches which should be combined when a
prioritisation strategy is applied. If a researcher decides to solely
rely on automatic prioritisation, GeneDistiller could be a valuable
resource to gather information about the candidate genes to
exclude some of them before the cost-intensive sequencing process
is started.
At present, GeneDistiller only offers information about human
genes. We are currently integrating mouse data, as mice are often
used as a model organism in gene hunting. Depending on the use
of GeneDistiller by the community and suggestions from the users,
other species, especially rat, might be added in the future.
Methods
Implementation
Database. The GeneDistiller database runs on PostgreSQL 8
under Debian Linux on an Intel QuadCore server with 8 GB of
RAM. It uses a strictly conventional schema, no special data types
or objects are used. Tables are connected with foreign keys to
ensure referential integrity. The database schema is query-
optimised and makes use of indexes whenever an attribute is
referenced or frequently included in queries.
Interfaces. All database user interfaces are web-accessible
using plain HTML and, for some functions such as the on-line
help, JavaScript. The query interface is dynamically generated
from a template, so that its elements can be created according to
the database contents and to allow the form to be filled out with
user settings specified in a GET or POST request. These settings
can either be included in a hyperlink given together with the
results or in a request made by another software when
GeneDistiller’s light API is used. To reduce the server’s load, a
static version of the query interface is created whenever data has
changed and used when not called with parameters. The interfaces
were developed with Firefox 2 and also tested on Internet Explorer
7 but so far, no problems with older versions or other browsers
have been reported.
Software. The software behind the interfaces was
programmed in Perl 5.8. Submitted data is read using the CGI
module, HTML::Template is used to create the query interface,
database connections are made with the DBI module and the
DBD::Pg database driver, bar charts are created with the GD
module and the Statistics::Basic::Correlation module is used to
calculate Pearson correlation for expression data.
Figure 4. Prioritisation / query interface (screenshot). This figure shows the query interface of GeneDistiller for the prioritisation example for
epilepsy described in the text. The interface is divided into different sections in which the parameters describing a similar aspect of the gene-specific
data are listed. Sections not used can be closed (e.g. ‘‘prioritisation settings’’). Please note that most of the available tissues in the expression section
are omitted to improve readability.
doi:10.1371/journal.pone.0003874.g004
GeneDistiller
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schemes for common approaches, e.g. tissue specific expression or
similarity with known disease genes. If a prioritisation approach has
been selected, the prioritisation section will open in the interface and
the preset weights assigned to each parameter will be filled in by
JavaScript. Users are absolutely free to change these settings to
values that better reflect their own preconception. After the database
was queried, all genes are scored according to their parameters’
fulfilment of the settings made in the query interface and the weight
assigned to each positive match. The genes are subsequently re-
ordered by their scores.
Expression similarity is calculated using Pearson correlation.
For this, the mean expression in any available tissue is used. This
value can be used for prioritisation (multiplied by the user-defined
weight), sorting and filtering. In the latter case, only genes with a
correlation higher than the specified factor are shown.
The computation of the similarity of the user specified tissue
specific expression is performed by comparison of each tissue’s
expression/median with the specified value. If the value is above
the user input and the operator is ‘greater then’ or if it is below
and ‘smaller then’ was selected, a positive score will be
generated; in other cases the score will be negative. The score
is calculated by division of the real expression/median by the
user entered value, if the result is negative, the inverse will be
taken. All scores for one gene are added to generate the final
similarity score.
Figure 5. Results page (screenshot). GeneDistiller prints all results on a single HTML page. The genes are listed in the selected order, in case of
prioritisation strategies also with their over-all scores and sub scores for different parameters. The gene specific data is presented with hyperlinks to
the original data sources. Keywords or values that were used for filtering or highlighting are printed in bold letters. The same applies to values that
are present in other genes known to be related with the selected disease (epilepsy, in this case). Please note that many NCBI GeneRIFs and OMIM
reports for SCN1A were omitted in this figure to improve readability.
doi:10.1371/journal.pone.0003874.g005
Table 1. Integrated data sources.
Genes & transcripts
NCBI Entrez Gene [21] http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene
ENSEMBL [22] http://www.ensembl.org/index.html
NCBI GeneRIFs [23] http://www.ncbi.nlm.nih.gov/sites/entrez?db=gee
Genetic markers
dbSNP [24] http://www.ncbi.nlm.nih.gov/sites/entrez?db=Snp
UniSTS [4] http://www.ncbi.nlm.nih.gov/sites/entrez?db=unists
Mitochondrial proteins
Maestro [25] http://www.nature.com/ng/journal/v38/n5/suppinfo/ng1776_S1.html
Mitopred [26] http://www.nature.com/ng/journal/v38/n5/suppinfo/ng1776_S1.html
Protein domains, families and paralogs
ENSEMBL [22] http://www.ensembl.org/index.html
InterPro [27] http://www.ebi.ac.uk/interpro/
Pfam [28] http://www.sanger.ac.uk/Software/Pfam/
Protein functions
GeneOntology [15] http://geneontology.org/
Pathways
KEGG [29] http://www.genome.jp/kegg/
Cellular localisations
GeneOntology [15] http://geneontology.org/
Phenotypes / diseases (human)
OMIM [1] http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM
Phenotypes (mouse)
MGD [30] http://www.informatics.jax.org/
Interactions
UniHI [31] http://www.mdc-berlin.de/unihi
Gene expression
GeneAtlas [32] http://wombat.gnf.org/index.html
External IDs
Swiss-Prot [33] http://expasy.org/sprot/
UCSC [5] http://genome.ucsc.edu/
The table lists the different data sources that are included in Gene Distiller. The data is regularly updated.
doi:10.1371/journal.pone.0003874.t001
GeneDistiller
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ogy) will also find descendants (subclasses) of an entity, e.g.
querying for DNA repair will also find genes, which do not carry
this term but its subclasses base-excision repair or mismatch repair
instead. To achieve this, a recursive query is carried out using a
PL/pgSQL function. Results are written into a temporary table
and then used by GeneDistiller to either restrict a query or to
highlight values (or their subclasses) matching the user’s request.
API. The query interface and the results page accept input
submitted as GET or POST requests and will generate and return
the according HTML page. All settings which can be made in the
query interface can also be included in such a call. A complete list
of the options with examples is given on GeneDistiller’s website.
Please note that the use of the data collected in GeneDistiller
might require a license.
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